Kymera Stock 130%: $135 Million Buy Boosts Immunology Bet
A major stake in Kymera Therapeutics highlights growing investor optimism in targeted protein degradation. This artic...
A clear look at the stablecoins that outperformed peers this year, with insights into drivers and risk considerations for future allocations.
26,211 articlesA major stake in Kymera Therapeutics highlights growing investor optimism in targeted protein degradation. This artic...
Housing leaders say President Trump’s plan must address supply, permitting and consumer protections in addition to mo...
Canopy Growth has seen dramatic swings, trading under $2 after years of highs. This guide breaks down what could push...
When big deals fall apart, investors face a new reality. This guide breaks down Netflix after deal collapse, spells o...
McDonald’s unveils a $3 meal, intensifying the battle for America’s cheapest menu. Investors weigh margin risk as val...
China is pivoting from selling finished goods to supplying key components for assembly abroad, fueling Southeast Asia...
Nokia climbs on 5G demand and North American telecom spend, while broader markets drift. A practical look at what thi...
Pete Davidson has trimmed the price of his Westchester home to $2.15 million as he eyes a move to Staten Island, sign...
Today’s market moved in Ford’s favor as analysts primed optimism around Ford’s energy initiatives alongside its tradi...
SpaceX rumors spark a rally in the Procure Space ETF, with the fund tracking the space economy as investors eye a pot...
A trio of municipal bond ETFs could deliver about $21,000 per year in federally tax-exempt income from a $500,000 sta...
As investors seek durable AI upside beyond chips, three ETFs focusing on the software layer beat peers and promise re...